Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prodactariv
- Development stage
- Unknown
- Lead developer
- International Drug Agency for Pharmaceutical Industry
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Prodactariv is a pharmaceutical drug that contains Daclatasvir as its active ingredient. Daclatasvir is a direct-acting antiviral (DAA) medication specifically designed to treat chronic hepatitis C virus (HCV) infection. It functions by inhibiting the non-structural protein 5A (NS5A) of the hepatitis C virus, which is crucial for viral replication and assembly. By binding to a specific domain within NS5A, Daclatasvir disrupts the virus's ability to synthesize RNA and form new viral particles. Prodactariv is typically administered orally in combination with other antiviral agents, such as sofosbuvir, for the treatment of various HCV genotypes, including genotypes 1, 3, and 4. It is manufactured by the International Drug Agency for Pharmaceutical Industry (IDI), Egypt.
- Brand names
- Prodactariv
02
Targets
NS5A (Hepatitis C virus nonstructural protein 5A (genotype 1b))
Beyond the preview
Go deeper on Prodactariv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prodactariv.